A detailed history of Avitas Wealth Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Avitas Wealth Management LLC holds 22,048 shares of ABT stock, worth $2.52 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
22,048
Previous 28,265 22.0%
Holding current value
$2.52 Million
Previous $2.94 Million 14.44%
% of portfolio
0.36%
Previous 0.44%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$100.07 - $118.13 $622,135 - $734,414
-6,217 Reduced 22.0%
22,048 $2.51 Million
Q2 2024

Jul 24, 2024

SELL
$100.73 - $112.44 $36,766 - $41,040
-365 Reduced 1.27%
28,265 $2.94 Million
Q1 2024

Apr 24, 2024

SELL
$109.52 - $120.96 $56,950 - $62,899
-520 Reduced 1.78%
28,630 $3.25 Million
Q4 2023

Jan 24, 2024

BUY
$90.19 - $110.4 $11,003 - $13,468
122 Added 0.42%
29,150 $3.21 Million
Q3 2023

Nov 02, 2023

SELL
$95.53 - $114.62 $60,948 - $73,127
-638 Reduced 2.15%
29,028 $2.81 Million
Q2 2023

Jul 18, 2023

SELL
$100.78 - $112.29 $33,660 - $37,504
-334 Reduced 1.11%
29,666 $3.23 Million
Q1 2023

May 15, 2023

SELL
$96.86 - $114.01 $33,901 - $39,903
-350 Reduced 1.15%
30,000 $3.04 Million
Q4 2022

Jan 10, 2023

BUY
$95.06 - $111.52 $483,094 - $566,744
5,082 Added 20.11%
30,350 $0
Q3 2022

Oct 27, 2022

SELL
$96.76 - $112.03 $348,819 - $403,868
-3,605 Reduced 12.49%
25,268 $2.45 Million
Q2 2022

Jul 29, 2022

SELL
$102.07 - $123.37 $724,492 - $875,680
-7,098 Reduced 19.73%
28,873 $3.14 Million
Q1 2022

Apr 28, 2022

SELL
$114.02 - $139.04 $665,990 - $812,132
-5,841 Reduced 13.97%
35,971 $4.26 Million
Q4 2021

Jan 26, 2022

BUY
$115.53 - $141.46 $1.17 Million - $1.44 Million
10,166 Added 32.12%
41,812 $5.89 Million
Q3 2021

Oct 28, 2021

BUY
$116.66 - $129.06 $846,601 - $936,588
7,257 Added 29.76%
31,646 $3.74 Million
Q2 2021

Jul 12, 2021

BUY
$105.79 - $124.53 $58,078 - $68,366
549 Added 2.3%
24,389 $2.83 Million
Q1 2021

May 13, 2021

SELL
$108.84 - $128.23 $188,293 - $221,837
-1,730 Reduced 6.77%
23,840 $2.86 Million
Q4 2020

Feb 26, 2021

SELL
$105.0 - $114.42 $5,145 - $5,606
-49 Reduced 0.19%
25,570 $2.8 Million
Q3 2020

Oct 06, 2020

SELL
$91.64 - $111.29 $22,910 - $27,822
-250 Reduced 0.97%
25,619 $2.79 Million
Q2 2020

Jul 30, 2020

SELL
$76.57 - $98.0 $71,746 - $91,826
-937 Reduced 3.5%
25,869 $2.37 Million
Q1 2020

May 13, 2020

SELL
$62.82 - $91.86 $512,674 - $749,669
-8,161 Reduced 23.34%
26,806 $2.12 Million
Q4 2019

Feb 13, 2020

BUY
$78.51 - $87.4 $25,751 - $28,667
328 Added 0.95%
34,967 $3.04 Million
Q3 2019

Oct 18, 2019

BUY
$81.84 - $88.74 $39,283 - $42,595
480 Added 1.41%
34,639 $2.9 Million
Q2 2019

Jul 23, 2019

BUY
$72.88 - $85.0 $2.49 Million - $2.9 Million
34,159 New
34,159 $2.87 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Avitas Wealth Management LLC Portfolio

Follow Avitas Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avitas Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avitas Wealth Management LLC with notifications on news.